News Positive Results in Phase 3 Study of Pyrukynd for Thalassemia Patients By Colin Kellaher Shares of Agios Pharmaceuticals saw a significant rise in premarket trading on Wednesday following the announcement of positive outcomes from ... By Artur FernandoJanuary 3, 20240
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024